Fresenius Medical Care is trading at $22.67, up 4.33%, as a broad pre-market rally and strength in healthcare point to market and sector sentiment.

  • A broad rally following reduced U.S. election uncertainty is lifting equities.
  • November 3 results included a narrowed 2026 operating-income outlook and declining U.S. treatment volumes, which do not clearly explain the current rise.
  • No reliable pre-market volume figure was available.